Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

This phase II, randomised, double-blind, multicentre study (NCT00930982) investigated the safety and efficacy of ciprofloxacin dry powder for inhalation (DPI) in patients with non-cystic fibrosis bronchiectasis. Adults who were culture positive for pre-defined potential respiratory pathogens (includ...

Full description

Saved in:
Bibliographic Details
Main Authors: Wilson, Robert, Welte, Tobias, Polverino, Eva, De Soyza, Anthony, Greville, Hugh, O'Donnell, Anne, Alder, Jeff, Reimnitz, Peter, Hampel, Barbara
Format: Artigo
Language:Inglês
Published: European Respiratory Society 2013
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640146/
https://ncbi.nlm.nih.gov/pubmed/23018904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00071312
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items